Covid-19 Vaccine At Least A Year Away, Says Merck Ceo

Covid-19 Vaccine at Least a Year Away, Says Merck CEO

David Rubenstein

Merck CEO Ken Frazier on coronavirus vaccine: 'You can't rush science'

CNBC Television

Merck CEO on Covid Pill Distribution, Vaccine Development

Bloomberg Television

Covid mRNA Vaccines Are 'Watershed Moment,' Says Merck CEO

Bloomberg Television

Merck CEO Expects No Layoffs Due to Covid-19 Pandemic

David Rubenstein

Merck Shuts Down Covid Vaccine Program After Lackluster Data

Bloomberg Quicktake

Former Merck vaccine head on Covid-19 vaccine timeline

CNBC Television

Merck ends COVID vaccine program

Merck Ready to Produce Hundreds of Millions of Doses of Covid-19 Vaccine

David Rubenstein

Merck ready to deploy Covid-19 antiviral pill upon FDA approval: CEO

CNBC Television

Merck Ends Development Of Two Potential COVID-19 Vaccines Over Poor Results In Early-Stage Studies

Fauci on Child Vaccinations, Boosters and Merck Covid Pill

Bloomberg Television

Merck's outgoing CEO Ken Frazier: 'Not in my plans' to run for office

CNBC Television

Coronavirus: Merck CEO on the race to develop a vaccine

CNBC Television

Merck helps produce vaccine as Biden says US will have vaccines for all adults by end of May | FOX 9

FOX 9 Minneapolis-St. Paul

Merck CEO Ken Frazier & Tsedal Neeley talk COVID Vaccines, Racism & Why Leaders Need to Really Act

Merck's Covid Pill Is 'Good News' But Vaccines Still Key, White House Says

Bloomberg Quicktake

Pfizer CEO: ‘We need to come with a vaccine that is lasting at least a year’

Moderna to charge $25-$37 for COVID-19 vaccine, says CEO

WION

Merck joins the race for a COVID-19 vaccine

NJ Spotlight News